Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "009218."
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
10MG |
| Application Number: |
N009218 |
| Product Number: |
005 |
| Approval Date: |
Approved Prior to Jan 1, 1982 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
5MG |
| Application Number: |
N009218 |
| Product Number: |
007 |
| Approval Date: |
Approved Prior to Jan 1, 1982 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
2MG |
| Application Number: |
N009218 |
| Product Number: |
013 |
| Approval Date: |
Approved Prior to Jan 1, 1982 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
7.5MG |
| Application Number: |
N009218 |
| Product Number: |
016 |
| Approval Date: |
Approved Prior to Jan 1, 1982 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
2.5MG |
| Application Number: |
N009218 |
| Product Number: |
018 |
| Approval Date: |
Approved Prior to Jan 1, 1982 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
1MG |
| Application Number: |
N009218 |
| Product Number: |
022 |
| Approval Date: |
Mar 1, 1990 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
4MG |
| Application Number: |
N009218 |
| Product Number: |
023 |
| Approval Date: |
Aug 24, 1993 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
INJECTABLE; INJECTION |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
5MG/VIAL |
| Application Number: |
N009218 |
| Product Number: |
024 |
| Approval Date: |
Feb 7, 1995 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
3MG |
| Application Number: |
N009218 |
| Product Number: |
025 |
| Approval Date: |
Nov 18, 1996 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
WARFARIN SODIUM |
| Dosage Form;Route: |
TABLET; ORAL |
| Proprietary Name: |
COUMADIN |
| Applicant: |
BRISTOL MYERS SQUIBB |
| Strength: |
6MG |
| Application Number: |
N009218 |
| Product Number: |
026 |
| Approval Date: |
Nov 18, 1996 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
Return to Electronic Orange Book Home Page
|
FDA/Center for Drug Evaluation and Research
|
|
Office of Generic Drugs
|
|
Division of Labeling and Program Support
|
|
Update Frequency: |
|
Orange Book Data - Monthly
|
|
Generic Drug Product Information & Patent Information - Daily
|
|
Orange Book Data Updated Through May, 2013
|
|
Patent and Generic Drug Product Data Last Updated: June 19, 2013
|
-
